Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits?

被引:8
作者
Chanson, P [1 ]
机构
[1] UNIV PARIS 11,LE KREMLIN BICETR,FRANCE
关键词
D O I
10.1530/eje.0.1360359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:359 / 361
页数:3
相关论文
共 18 条
[1]   SOMATOSTATIN ANALOG SANDOSTATIN AND INHIBITION OF TUMOR-GROWTH IN PATIENTS WITH METASTATIC ENDOCRINE GASTROENTEROPANCREATIC TUMORS [J].
ARNOLD, R ;
NEUHAUS, C ;
BENNING, R ;
SCHWERK, WB ;
TRAUTMANN, ME ;
JOSEPH, K ;
BRUNS, C .
WORLD JOURNAL OF SURGERY, 1993, 17 (04) :511-519
[2]  
BERTHERAT J, 1993, J CLIN ENDOCR METAB, V77, P1577, DOI 10.1210/jc.77.6.1577
[3]   Prediction of efficacy of octreotide therapy in patients with acromegaly [J].
Colao, A ;
Ferone, D ;
Lastoria, S ;
Marzullo, P ;
Cerbone, G ;
DiSarno, A ;
Longobardi, S ;
Merola, B ;
Salvatore, M ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2356-2362
[4]   CLINICALLY NONFUNCTIONING PITUITARY-ADENOMA AND OCTREOTIDE RESPONSE TO LONG-TERM HIGH-DOSE TREATMENT, AND STUDIES INVITRO [J].
DEBRUIN, TWA ;
KWEKKEBOOM, DJ ;
VANTVERLAAT, JW ;
REUBI, JC ;
KRENNING, EP ;
LAMBERTS, SWJ ;
CROUGHS, RJM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) :1310-1317
[5]   SOMATOSTATIN RECEPTOR IMAGING IN NONFUNCTIONING PITUITARY-ADENOMAS - VALUE OF AN UPTAKE INDEX [J].
DUET, M ;
MUNDLER, O ;
AJZENBERG, C ;
BEROLATTI, B ;
CHEDIN, P ;
DURANTEAU, L ;
WARNET, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (07) :647-650
[6]   INVIVO DETECTION OF SOMATOSTATIN RECEPTORS IN PATIENTS WITH FUNCTIONLESS PITUITARY-ADENOMAS BY MEANS OF A RADIOIODINATED ANALOG OF SOMATOSTATIN ([I-123]SDZ 204-090) [J].
FAGLIA, G ;
BAZZONI, N ;
SPADA, A ;
AROSIO, M ;
AMBROSI, B ;
SPINELLI, F ;
SARA, R ;
BONINO, C ;
LUNGHI, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) :850-856
[7]   Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: Six-month report on an Italian multicenter study [J].
Giusti, M ;
Gussoni, G ;
Cuttica, CM ;
Giordano, G ;
Camanni, F ;
Ciccarelli, E ;
Dallabonzana, D ;
Strada, S ;
Delitala, G ;
Porcu, L ;
Faglia, G ;
Arosio, M ;
Liuzzi, A ;
Ghiggi, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2089-2097
[8]   [IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - THE PREDICTIVE VALUE FOR SOMATOSTATIN ANALOG TREATMENT [J].
JANSON, ET ;
WESTLIN, JE ;
ERIKSSON, B ;
AHLSTROM, H ;
NILSSON, S ;
OBERG, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (06) :577-581
[9]   SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS [J].
KRENNING, EP ;
KWEKKEBOOM, DJ ;
BAKKER, WH ;
BREEMAN, WAP ;
KOOIJ, PPM ;
OEI, HY ;
VANHAGEN, M ;
POSTEMA, PTE ;
DEJONG, M ;
REUBI, JC ;
VISSER, TJ ;
REIJS, AEM ;
HOFLAND, LJ ;
KOPER, JW ;
LAMBERTS, SWJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (08) :716-731
[10]   OCTREOTIDE AND RELATED SOMATOSTATIN ANALOGS IN THE DIAGNOSIS AND TREATMENT OF PITUITARY DISEASE AND SOMATOSTATIN RECEPTOR SCINTIGRAPHY [J].
LAMBERTS, SWJ ;
HOFLAND, LJ ;
DEHERDER, WW ;
KWEKKEBOOM, DJ ;
REUBI, JC ;
KRENNING, EP .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (01) :27-55